The Manufacturers Life Insurance Company Acquires Shares of 339,490 Corteva, Inc. $CTVA

The Manufacturers Life Insurance Company bought a new position in shares of Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 339,490 shares of the company’s stock, valued at approximately $28,750,000.

A number of other institutional investors have also made changes to their positions in CTVA. Arbejdsmarkedets Tillaegspension acquired a new stake in shares of Corteva in the fourth quarter valued at approximately $23,679,000. Bank of New York Mellon Corp acquired a new position in Corteva during the 2nd quarter worth $392,447,000. Leonteq Securities AG bought a new position in Corteva in the 4th quarter valued at $2,350,000. Brandes Investment Partners LP boosted its position in Corteva by 1.1% in the 4th quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock valued at $155,009,000 after buying an additional 24,985 shares during the last quarter. Finally, Twin Capital Management Inc. increased its stake in shares of Corteva by 178.9% in the 4th quarter. Twin Capital Management Inc. now owns 25,394 shares of the company’s stock valued at $1,702,000 after buying an additional 16,288 shares during the period. 81.54% of the stock is owned by institutional investors.

Corteva Stock Down 0.7%

Shares of Corteva stock opened at $82.27 on Friday. The business has a fifty day simple moving average of $82.58 and a 200 day simple moving average of $80.52. The stock has a market cap of $54.89 billion, a PE ratio of 54.48, a price-to-earnings-growth ratio of 2.54 and a beta of 0.57. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97.

Corteva (NYSE:CTVA) last issued its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The firm had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company’s revenue was down 1.2% compared to the same quarter last year. During the same quarter last year, the business earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Research analysts predict that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Analyst Upgrades and Downgrades

CTVA has been the subject of a number of recent research reports. BMO Capital Markets boosted their target price on Corteva from $95.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, August 3rd. Mizuho boosted their price objective on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a report on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $101.00 target price on shares of Corteva in a research report on Monday, August 3rd. Bank of America raised their target price on shares of Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research note on Monday, July 20th. Finally, Citigroup lifted their price target on shares of Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a research report on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $91.50.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.